Biomarkers in Cardiovascular Diseases: 1st Edition (Hardback) book cover

Biomarkers in Cardiovascular Diseases

1st Edition

Edited by Dimitris Tousoulis, Christodoulos Stefanadis

CRC Press

442 pages | 10 B/W Illus.

Purchasing Options:$ = USD
Hardback: 9781466587144
pub: 2013-07-29
$205.00
x
eBook (VitalSource) : 9780429168437
pub: 2013-07-29
from $28.98


FREE Standard Shipping!

Description

The establishment of precise and reliable biomarker tests for the early stages of cardiovascular disease is of great importance and can be the cornerstone in the prevention of future cardiovascular disease (CVD). Furthermore, some biomarkers may provide important information concerning the pathogenesis of CVD or appear to be useful in risk stratification, in CVD diagnosis, or in monitoring therapy; many others may be risk factors themselves, representing therefore potential targets of therapy. The ideal biomarker should have the following characteristics: highly sensitive, specific, reliable, accessible, standardized, dependable, cost effective, and easily interpretable by clinicians.

The present book focuses on the presentation and evaluation of the most promising classical and novel biochemical markers used in CVD (coronary artery disease, hypertension, heart failure, hyperlipidemia, peripheral arterial disease). The underlying pathophysiological characteristics of each biomarker, as well as potential clinical implications in daily practice are reviewed in this book.

Reviews

"In summary, [the book] offers a comprehensive review of well-selected promising biomarkers for (potential) use in the entire spectrum of cardiovascular diseases. In doing so, the book is of interest for basic and clinical cardiovascular scientists as well as for clinicians with an interest in biomarker research."

—Tobias J. Reichlin, MD, Boston, Massachusetts, USA, in the European Heart Journal

Table of Contents

Part I: Classical biomarkers

C-reactive protein in cardiovascular disease

Dimitris Tousoulis MD PhD FACC FESC, Emmanuel Androulakis MD MSc, Nikolaos Papageorgiou, MD, Christodoulos Stefanadis MD PhD FACC FESC

Biomarkers in early atherosclerosis

Dimitris Tousoulis MD, PhD, FACC, FESC, Anna-Maria Kampoli, MD, George Latsios MD, Gerasimos Siasos MD, Christodoulos Stefanadis, MD, FACC, FESC

Biomarkers in essential hypertension

Emmanuel Androulakis MD, Dimitris Tousoulis MD PhD FACC FESC, Nikolaos Papageorgiou MD, Christodoulos Stefanadis MD PhD FESC FACC

Biomarkers in hyperlipidemia

Dimitris Tousoulis MD PhD FACC FESC, Emmanuel Androulakis MD MSc, Nikolaos Papageorgiou, MD,George Latsios MD, Gerasimos Siasos MD, Evangelos Oiconomou MD, Christodoulos Stefanadis MD PhD FESC FACC

Cardiac biomarkers in acute coronary syndromes

Konstantinos Toutouzas MD, Andreas Synetos MD, Maria Drakopoulou MD, Dimitris Tousoulis MD, Christodoulos Stefanadis MD

Biomarkers in congestive heart failure

Chiara Andreoli, MD, John T. Parissis, MD

Biomarkers of Pulmonary Hypertension and Pulmonary Embolism

Helias Stamatopoulos MD, Stella Brili MD

Coronary artery by-pass grafting and biomarkers

Constantina Aggeli MD, Ioannis Felekos MD, Emanuel Poulidakis MD, Iosif Koutagiar MD, Erifili Venieri MD, Christodoulos Stefanadis MD, FACC, FESC

Biomarkers of peripheral arterial disease

Marietta Charakida MD, PhD, Dimitris Tousoulis MD, PhD

Biomarkers in cardiorenal syndrome

Costas Tsioufis MD, Themistoklis Katsimichas MD, Anastasios Milkas MD, Dimitris Tousoulis MD, PhD, FACC, FESC

Cardiac arrhythmias: is there a role for biomarkers?

Polychronis Dilaveris, MD, FESC, Konstantinos Gatzoulis, MD, Dimitris Tousoulis, MD, PhD, FESC, FACC, Christodoulos Stefanadis, MD, FESC, FACC

The role of biomarkers in the antiplatelet treatment

Gerasimos Siasos MD, MSc, PhD, Dimitris Tousoulis MD, PhD, FACC, Marina Zaromitidou MD, Evangelos Oikonomou MD, Christodoulos Stefanadis MD, PhD, FACC, FESC

Part II: Novel biomarkers

Novel biomarkers used in the assessment of acute coronary syndrome

Dimitris Tousoulis MD PhD FACC FESC, Emmanuel Androulakis MD MSc, Nikolaos Papageorgiou, MD, Christodoulos Stefanadis MD PhD FESC

Novel cardiac biomarkers and application to heart failure

Evangelos Oikonomou MD, Dimitris Tousoulis MD, PhD, FACC, Gerasimos Siasos MD, PhD, Nikolaos Papageorgiou MD, Christodoulos Stefanadis MD, PhD, FACC, FESC

The role of genetic traits in cardiovascular disease

Alexios S. Antonopoulos MD, Regent Lee MD, PhD, Dimitris Tousoulis MD, PhD, Charalambos Antoniades MD, PhD

MicroRNAs: a novel cardiac biomarker

Nikolaos Papageorgiou MD, Dimitris Tousoulis MD PhD FACC FESC, Anna Kontogeorgou MD, Emmanuel Androulakis MD, Christodoulos Stefanadis MD PhD FACC FESC

About the Editors

Dimitris Tousoulis, Christodoulos Stefanadis

Subject Categories

BISAC Subject Codes/Headings:
MED010000
MEDICAL / Cardiology
MED079000
MEDICAL / Pulmonary & Thoracic Medicine